Verification of EZH2 as a Druggable Target in Metastatic Uveal Melanoma

Molecular Cancer - United Kingdom
doi 10.1186/s12943-020-01173-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC